Capstone Investment Advisors »

Amylyx Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $294k 20k 14.72
2023-09-30 $418k 23k 18.31
2023-03-31 $298k 10k 29.34

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Select Sector Spdr Tr Financial Call Option (XLF)
Broadcom Call Option (AVGO)

View all positions for Capstone Investment Advisors

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals